Exosect's Lean Formulation Technology™ nominated for Agrow Award

Exosect’s proprietary formulation platform selected as finalist for leading crop protection award
19 July 2016

Winchester, UK – Exosect Ltd., a pioneer in Lean Formulation Technology™, is delighted to announce that its proprietary formulation platform, Entostat®, has been selected as a finalist for the prestigious Agrow Awards in the category of Best Application Technology Innovation. This category applies to technologies such as adjuvants used to improve the precision or safety of pesticide applications.

The awards ceremony, which will be held at Banking Hall, London, on the 21st September 2016, honours individuals and companies who have achieved high standards in the crop protection and agrochemical industry during the past year.

Entostat is a proprietary micro-powder, based on natural and/or synthetic waxes and has electrostatic properties. It is a lean formulation delivery platform for a wide range of synthetic and biological active ingredients. It enables a significant reduction of synthetic active ingredient with equivalent or improved efficacy. Importantly, the constituents of Entostat are listed on FIFRA 25(b)1 list of inert ingredients that can be used in pesticide products that are exempt from regulation.

Earlier this year, Dr. Aoife Dillon, Chief Technology Officer, summarised Exosect’s lean formulation technology platform at Crops & Chemicals Europe.

Exosect news link: www.exosect.com/news/news-detail.aspx?id=104